Ilant Health Raises $15M to Advance Obesity Care
Ilant Health's Series A round was led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, Celtic, LifeX and AlphaLab.
Telehealth is Making GLP-1s More Accessible – But Access Alone isn’t Enough
Providing access to GLP-1s only solves part of the problem. In fact, without a broader approach, it may lead to new challenges alongside the ones it aims to address.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable
We have to cover medical nutrition therapy for those who need it most, including Medicare beneficiaries. Almost all commercial payers are already doing this - the government needs to catch up.
The Weight Loss Market in 2026: 3 Questions That Will Shape the Next Decade
The weight loss market is at yet another inflection point. The euphoria of the past three years is now confronting the realities of how obesity medications will scale to address an epidemic that impacts over 1 billion people globally.
What if Less Can Be More? A New Approach to GLP-1 Weight Loss Medications
Microdosing won’t be the right choice for everyone. But for many patients, it’s already proving to be the difference between quitting obesity treatment early and making lasting progress.
It’s the End Of the Line for One‑Size‑Fits‑All Weight Loss
Instead of viewing obesity as one uniform condition, experts now recognize that it can arise from multiple biological patterns. Understanding that difference could finally change how we approach treatment altogether.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Withings Health Solutions Expands Obesity Care Network, Launches Best Practices for Treatment Programs
Withings Health Solutions added Ilant Health to its Obesity Care Network and shared best practices to improve patient monitoring, engagement and outcomes.
Turning the Page for Obesity Therapies — Addressing Tolerability and Delivery
As scientists and researchers figure out the right balance of GLP-1 to glucagon ratio and a better drug delivery method, we are beginning to turn the page for the many individuals suffering from obesity.
More than 65 Organizations Call on Workplaces to Provide Comprehensive Obesity Care Coverage
The Alliance for Women’s Health and Prevention and several other organizations are urging employers to cover the "full range of evidence-based obesity care options," including medical nutrition therapy, intensive behavioral therapy, surgery and medications.
Knownwell Opens 6 New Clinics in Chicago
Obesity care company knownwell expanded into six new clinic locations across greater Chicago. The company now operates eight clinics, as it has existing locations in Boston and Dallas. Knownwell also provides virtual care services to patients across New England, Texas and Illinois.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
presented by
GVX Venture Studio Launches FusionCare.AI: A One-Stop Shop for Obesity Care at the Future and Health Executive Summit at JPM 2025
Combining AI-driven insights with tailored care pathways, patients gain access to health coaches, psychologists, and treatment plans, while providers benefit from workflow optimization.
The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care
Pricy GLP-1 medications are here to stay — let's focus on turning their potential into lasting, meaningful impact.
A Recipe for Better Obesity Care: Integrating GLP-1s with Food as Medicine
Nutrition isn’t a supplement — it’s foundational to metabolic health. It’s time we integrate more ‘Food as Medicine’ initiatives alongside the GLP-1 therapies that are gaining traction.
Redefining Clinical Development of Obesity Drugs: What Does Success Look Like?
As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers.
Rising to the 100M Patient Challenge, Tech’s Role in Scaling Obesity Care
With so many now seeking GLP-1 treatment, we must find ways to help providers care for more patients. Technology is the key to unlocking this capacity.